SRZN · NASDAQ
Surrozen (SRZN) Stock Price & Fundamentals
Surrozen (SRZN) closed at $302.01 on Oct 9, 2026, down 0.21% from the previous close of $302.64.
Share price, past year
1Y −3.21%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $302.01 |
| Sep 30, 2026 | $299.31 |
| Aug 31, 2026 | $292.88 |
| Jul 31, 2026 | $295.78 |
| Jun 30, 2026 | $314.92 |
| May 29, 2026 | $329.67 |
| Apr 30, 2026 | $338.63 |
| Mar 31, 2026 | $340.73 |
| Feb 27, 2026 | $340.18 |
| Jan 30, 2026 | $325.62 |
| Dec 31, 2025 | $302.44 |
| Nov 28, 2025 | $311.92 |
| Oct 31, 2025 | $320.63 |
Key statistics
- Market cap
- $3.55B
- P/E (TTM)
- —
- EPS (TTM)
- −$39.55
- Revenue (TTM)
- $11.51M
- Net income (TTM)
- −$332.13M
- Shares outstanding
- 11.8M
- Dividend yield
- —
- 52-week range
- $285.85 – $350.18
Surrozen's market cap is $3.55B, based on a share price of $302.01 and 11.8M shares outstanding as of Jun 30, 2026.
Financials
Surrozen reported revenue of $3.48M for fiscal 2025, down 67.37% from fiscal 2024.
Surrozen reported a net loss of $242.03M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $3.48M | −67.4% | −$242.03M | −6,960.8% | −$32.37 | −$30.37M |
| FY2024ended Dec 31, 2024 | $10.66M | — | −$63.56M | −596.6% | −$21.67 | −$17.65M |
| FY2023ended Dec 31, 2023 | $0.00 | −100.0% | −$43.04M | — | −$21.33 | −$40.76M |
| FY2022ended Dec 31, 2022 | $12.50M | — | −$36.00M | −288.0% | −$15.56 | −$44.87M |
| FY2021ended Dec 31, 2021 | $0.00 | — | −$54.65M | — | −$2.21 | −$50.08M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $5.00M | $50.18M | −$0.41 |
| Q1 FY2026ended Mar 31, 2026 | $5.00M | −$127.51M | −$11.65 |
| Q4 FY2025ended Dec 31, 2025 | $528.00K | −$183.16M | −$19.13 |
| Q3 FY2025ended Sep 30, 2025 | $983.00K | −$71.64M | −$8.36 |
| Q2 FY2025ended Jun 30, 2025 | $983.00K | $39.75M | $2.55 |
| Q1 FY2025ended Mar 31, 2025 | $983.00K | −$26.97M | −$7.43 |
| Q4 FY2024ended Dec 31, 2024 | $655.00K | −$28.04M | −$9.00 |
| Q3 FY2024ended Sep 30, 2024 | $10.00M | −$1.43M | −$0.44 |
Company profile
- Name
- Surrozen, Inc./DE
- Ticker
- SRZN
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Biological Products, (No Diagnostic Substances)
- Headquarters
- 171 Oyster Point Blvd, Suite 400, South San Francisco, CA 94080
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001824893
Recent SEC filings
- Oct 2, 2026
- Aug 6, 2026
- Aug 6, 2026
- May 14, 2026
- May 6, 2026
- May 6, 2026
- Mar 23, 2026
- Mar 23, 2026
Frequently asked questions
What is Surrozen's stock price?
Surrozen (SRZN) closed at $302.01 on Oct 9, 2026, down 0.21% from the previous close of $302.64.
What is Surrozen's market cap?
Surrozen's market cap is $3.55B, based on a share price of $302.01 and 11.8M shares outstanding as of Jun 30, 2026.
How much revenue does Surrozen make?
Surrozen reported revenue of $3.48M for fiscal 2025, down 67.37% from fiscal 2024.
Does Surrozen pay a dividend?
Surrozen's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Surrozen, Inc./DE's filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures